vs
Side-by-side financial comparison of Ameren (AEE) and BeOne Medicines Ltd. (ONC). Click either name above to swap in a different company.
Ameren is the larger business by last-quarter revenue ($1.8B vs $1.5B, roughly 1.2× BeOne Medicines Ltd.). Ameren runs the higher net margin — 14.2% vs 4.4%, a 9.8% gap on every dollar of revenue. On growth, BeOne Medicines Ltd. posted the faster year-over-year revenue change (32.8% vs -8.2%). BeOne Medicines Ltd. produced more free cash flow last quarter ($379.8M vs $-54.0M). Over the past eight quarters, BeOne Medicines Ltd.'s revenue compounded faster (41.2% CAGR vs -0.9%).
Ameren Corporation, together with its subsidiaries, operates as a public utility holding company in the United States. It operates through four segments: Ameren Missouri, Ameren Illinois Electric Distribution, Ameren Illinois Natural Gas, and Ameren Transmission. The company engages in the rate-regulated electric generation, transmission, and distribution activities; and rate-regulated natural gas distribution and transmission businesses. It primarily generates electricity through coal, nucle...
BeOne Medicines Ltd.ONCEarnings & Financial Report
BeOne Medicines, formerly known as BeiGene, Ltd. is a multinational oncology company. It specializes in the development of drugs for cancer treatment.
AEE vs ONC — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $1.8B | $1.5B |
| Net Profit | $253.0M | $66.5M |
| Gross Margin | — | 90.5% |
| Operating Margin | 20.2% | 12.4% |
| Net Margin | 14.2% | 4.4% |
| Revenue YoY | -8.2% | 32.8% |
| Net Profit YoY | 21.6% | 143.8% |
| EPS (diluted) | $0.92 | $0.05 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $1.8B | $1.5B | ||
| Q3 25 | $2.7B | $1.4B | ||
| Q2 25 | $2.2B | $1.3B | ||
| Q1 25 | $2.1B | $1.1B | ||
| Q4 24 | $1.9B | $1.1B | ||
| Q3 24 | $2.2B | $1.0B | ||
| Q2 24 | $1.7B | $929.2M | ||
| Q1 24 | $1.8B | $751.7M |
| Q4 25 | $253.0M | $66.5M | ||
| Q3 25 | $641.0M | $124.8M | ||
| Q2 25 | $277.0M | $94.3M | ||
| Q1 25 | $290.0M | $1.3M | ||
| Q4 24 | $208.0M | $-151.9M | ||
| Q3 24 | $457.0M | $-121.3M | ||
| Q2 24 | $260.0M | $-120.4M | ||
| Q1 24 | $262.0M | $-251.2M |
| Q4 25 | — | 90.5% | ||
| Q3 25 | — | 86.1% | ||
| Q2 25 | — | 87.5% | ||
| Q1 25 | — | 85.2% | ||
| Q4 24 | — | 85.8% | ||
| Q3 24 | — | 83.0% | ||
| Q2 24 | — | 85.1% | ||
| Q1 24 | — | 83.4% |
| Q4 25 | 20.2% | 12.4% | ||
| Q3 25 | 30.6% | 11.5% | ||
| Q2 25 | 18.5% | 6.7% | ||
| Q1 25 | 20.5% | 1.0% | ||
| Q4 24 | 10.2% | -7.0% | ||
| Q3 24 | 27.0% | -12.0% | ||
| Q2 24 | 21.3% | -11.5% | ||
| Q1 24 | 20.4% | -34.8% |
| Q4 25 | 14.2% | 4.4% | ||
| Q3 25 | 23.7% | 8.8% | ||
| Q2 25 | 12.5% | 7.2% | ||
| Q1 25 | 13.8% | 0.1% | ||
| Q4 24 | 10.7% | -13.5% | ||
| Q3 24 | 21.0% | -12.1% | ||
| Q2 24 | 15.4% | -13.0% | ||
| Q1 24 | 14.4% | -33.4% |
| Q4 25 | $0.92 | $0.05 | ||
| Q3 25 | $2.35 | $0.08 | ||
| Q2 25 | $1.01 | $0.06 | ||
| Q1 25 | $1.07 | $0.00 | ||
| Q4 24 | $0.77 | $-0.10 | ||
| Q3 24 | $1.70 | $-0.09 | ||
| Q2 24 | $0.97 | $-0.09 | ||
| Q1 24 | $0.98 | $-0.19 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $13.0M | $4.5B |
| Total DebtLower is stronger | $19.4B | $836.4M |
| Stockholders' EquityBook value | $13.4B | $4.4B |
| Total Assets | $48.5B | $8.2B |
| Debt / EquityLower = less leverage | 1.45× | 0.19× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $13.0M | $4.5B | ||
| Q3 25 | $9.0M | $4.0B | ||
| Q2 25 | $11.0M | $2.8B | ||
| Q1 25 | $23.0M | $2.5B | ||
| Q4 24 | $7.0M | $2.6B | ||
| Q3 24 | $17.0M | $2.7B | ||
| Q2 24 | $19.0M | $2.6B | ||
| Q1 24 | $85.0M | $2.8B |
| Q4 25 | $19.4B | $836.4M | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $17.8B | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $13.4B | $4.4B | ||
| Q3 25 | $12.8B | $4.1B | ||
| Q2 25 | $12.3B | $3.8B | ||
| Q1 25 | $12.2B | $3.5B | ||
| Q4 24 | $12.1B | $3.3B | ||
| Q3 24 | $11.8B | $3.4B | ||
| Q2 24 | $11.5B | $3.4B | ||
| Q1 24 | $11.4B | $3.4B |
| Q4 25 | $48.5B | $8.2B | ||
| Q3 25 | $47.4B | $7.6B | ||
| Q2 25 | $46.6B | $6.3B | ||
| Q1 25 | $45.7B | $5.8B | ||
| Q4 24 | $44.6B | $5.9B | ||
| Q3 24 | $43.3B | $5.8B | ||
| Q2 24 | $42.3B | $5.7B | ||
| Q1 24 | $41.3B | $5.7B |
| Q4 25 | 1.45× | 0.19× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 1.47× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $956.0M | $417.3M |
| Free Cash FlowOCF − Capex | $-54.0M | $379.8M |
| FCF MarginFCF / Revenue | -3.0% | 25.4% |
| Capex IntensityCapex / Revenue | 56.7% | 2.5% |
| Cash ConversionOCF / Net Profit | 3.78× | 6.28× |
| TTM Free Cash FlowTrailing 4 quarters | $-775.0M | $941.7M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $956.0M | $417.3M | ||
| Q3 25 | $1.1B | $402.6M | ||
| Q2 25 | $862.0M | $263.6M | ||
| Q1 25 | $431.0M | $44.1M | ||
| Q4 24 | $817.0M | $75.2M | ||
| Q3 24 | $897.0M | $188.4M | ||
| Q2 24 | $557.0M | $-95.6M | ||
| Q1 24 | $492.0M | $-308.6M |
| Q4 25 | $-54.0M | $379.8M | ||
| Q3 25 | $116.0M | $354.5M | ||
| Q2 25 | $-204.0M | $219.8M | ||
| Q1 25 | $-633.0M | $-12.3M | ||
| Q4 24 | $-473.0M | $-17.3M | ||
| Q3 24 | $-240.0M | $54.7M | ||
| Q2 24 | $-445.0M | $-205.5M | ||
| Q1 24 | $-398.0M | $-465.1M |
| Q4 25 | -3.0% | 25.4% | ||
| Q3 25 | 4.3% | 25.1% | ||
| Q2 25 | -9.2% | 16.7% | ||
| Q1 25 | -30.2% | -1.1% | ||
| Q4 24 | -24.4% | -1.5% | ||
| Q3 24 | -11.0% | 5.5% | ||
| Q2 24 | -26.3% | -22.1% | ||
| Q1 24 | -21.9% | -61.9% |
| Q4 25 | 56.7% | 2.5% | ||
| Q3 25 | 36.6% | 3.4% | ||
| Q2 25 | 48.0% | 3.3% | ||
| Q1 25 | 50.7% | 5.0% | ||
| Q4 24 | 66.5% | 8.2% | ||
| Q3 24 | 52.3% | 13.3% | ||
| Q2 24 | 59.2% | 11.8% | ||
| Q1 24 | 49.0% | 20.8% |
| Q4 25 | 3.78× | 6.28× | ||
| Q3 25 | 1.72× | 3.22× | ||
| Q2 25 | 3.11× | 2.79× | ||
| Q1 25 | 1.49× | 34.71× | ||
| Q4 24 | 3.93× | — | ||
| Q3 24 | 1.96× | — | ||
| Q2 24 | 2.14× | — | ||
| Q1 24 | 1.88× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
